Kronos Bio Announces Participation in the Jefferies Virtual Healthcare Conference

San Mateo, Calif., and Cambridge, Mass., May 26, 2020 – Kronos Bio, Inc., dedicated to drugging transcriptional regulatory networks in cancer, today announced that Norbert Bischofberger, Ph.D., President and Chief Executive Officer will present at the Jefferies Virtual Healthcare Conference taking place June 2-4, 2020.

Presentation Date: Wednesday, June 3, 2020
Presentation Time: 4:30 PM ET

A webcast will be made available on the Company’s website at in the News and Events section. Following the live audio webcast, a replay will be available on the Company’s website for approximately 30 days.

About Kronos Bio, Inc.

About Kronos Bio

Kronos Bio is a biopharmaceutical company that seeks to transform patient outcomes by targeting the oncogenic transcription factors and their associated transcriptional regulatory networks (“TRNs”) that define the cancer phenotype. We leverage deep capabilities in systems biology, chemical biology and clinical translational expertise in order to map these oncogenic TRNs, screen for small molecule modulators and identify selective vulnerabilities.

For more information, please visit or follow the company on LinkedIn.

# # #

Kronos Bio Contact:
Christopher Wilfong
Chief Operating Officer